GeoWealth Management, LLC

Position in NVO — Novo Nordisk A S

CIK 1593387 CHICAGO, IL

Position in NVO

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$1,858,633

+$883,435 QoQ

Shares Held

38,770

+46.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#397

of 1,348 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GeoWealth Management, LLC holds $25,513,723 across 13 Drug Manufacturers - General names. NVO ranks #6 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,153	$4,981,233
2	ABBV	AbbVie Inc.	14,601	$3,674,195
3	AZN	Astrazeneca PLC	18,885	$3,580,973
4	JNJ	Johnson & Johnson	13,367	$3,394,816
5	NVS	Novartis AG	12,284	$1,925,148
6	NVO	Novo Nordisk A S This page	38,770	$1,858,633
7	MRK	Merck & Co., Inc.	11,907	$1,530,049
8	AMGN	Amgen Inc	2,746	$994,381

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,858,633	38,770	+46.1%	Shares	Other	2026-07-30
2026-03-31	$975,198	26,536	+15.5%	Shares	Other	2026-05-13
2025-12-31	$1,168,917	22,974	+36.9%	Shares	Other	2026-02-17
2025-09-30	$931,344	16,784	+10.5%	Shares	Other	2025-11-13
2025-06-30	$1,048,551	15,192	+43.1%	Shares	Other	2025-08-13
2025-03-31	$737,244	10,617	-34.2%	Shares	Other	2025-05-09
2024-12-31	$1,387,932	16,135	+7.8%	Shares	Other	2025-02-13
2024-09-30	$1,782,120	14,967	-28.8%	Shares	Other	2024-11-12
2024-06-30	$2,998,539	21,007	+55.7%	Shares	Other	2024-08-12
2023-12-31	$1,396,057	13,495	+4585.8%	Shares	Other	2024-02-13
2023-09-30	$26,190	288	—	Shares	Other	2023-11-13
No filing history on record for this holder in this stock.